HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hartmut Döhner Selected Research
Hartmut Döhner Research Topics
Disease
106
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2022 - 07/2003
60
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 08/2002
50
Neoplasms (Cancer)
01/2022 - 09/2002
41
Leukemia
01/2021 - 04/2002
11
Infections
01/2022 - 04/2005
11
Disease Progression
11/2020 - 11/2002
9
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 05/2006
8
Residual Neoplasm
01/2022 - 10/2004
7
Hematologic Neoplasms (Hematological Malignancy)
04/2020 - 04/2005
7
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2007 - 09/2002
6
Neutropenia
01/2022 - 04/2005
6
Chromosome Aberrations (Chromosome Abnormalities)
01/2020 - 01/2004
6
Acute Promyelocytic Leukemia
11/2019 - 02/2009
5
Multiple Myeloma
01/2022 - 07/2003
4
Lymphoma (Lymphomas)
02/2021 - 03/2003
4
Carcinogenesis
01/2017 - 01/2013
4
Melanoma (Melanoma, Malignant)
05/2013 - 09/2002
4
Hodgkin Disease (Hodgkin's Disease)
05/2012 - 04/2006
3
Febrile Neutropenia
01/2022 - 01/2020
3
Hemorrhage
01/2022 - 02/2009
3
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2009 - 09/2006
3
Lymphadenopathy
05/2008 - 08/2004
3
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
07/2007 - 08/2004
3
Breast Neoplasms (Breast Cancer)
03/2007 - 09/2002
2
Thrombocytopenia (Thrombopenia)
11/2021 - 01/2020
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2021 - 01/2013
2
Pathologic Complete Response
12/2020 - 12/2005
2
Trisomy (Trisomies)
01/2020 - 01/2004
2
Anemia
01/2016 - 02/2006
2
Fever (Fevers)
08/2014 - 04/2005
2
Hematologic Diseases (Blood Diseases)
06/2014 - 06/2013
Drug/Important Bio-Agent (IBA)
16
fludarabine
IBA
01/2022 - 08/2004
15
Rituximab (Mabthera)
FDA Link
01/2022 - 09/2011
15
Proteins (Proteins, Gene)
FDA Link
01/2021 - 12/2005
15
Antigens
IBA
01/2019 - 09/2002
14
Azacitidine (5 Azacytidine)
FDA Link
10/2022 - 07/2015
11
Nucleophosmin
IBA
01/2019 - 12/2005
10
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2022 - 02/2006
10
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 03/2003
10
MicroRNAs (MicroRNA)
IBA
01/2020 - 02/2011
10
Tretinoin (Retinoic Acid)
FDA Link
Generic
01/2020 - 01/2009
8
Core Binding Factors (Core-Binding Factor)
IBA
12/2020 - 08/2007
7
midostaurin
IBA
01/2022 - 01/2017
7
Messenger RNA (mRNA)
IBA
04/2013 - 09/2002
6
Cytarabine (Cytosar-U)
FDA Link
Generic
08/2021 - 03/2007
6
Biomarkers (Surrogate Marker)
IBA
01/2019 - 11/2008
6
Biological Products
IBA
01/2016 - 08/2002
5
venetoclax
IBA
10/2022 - 03/2014
5
Lenalidomide (CC 5013)
FDA Link
01/2022 - 03/2013
5
Transcription Factors (Transcription Factor)
IBA
01/2021 - 04/2005
5
Immunoglobulins (Immunoglobulin)
IBA
11/2020 - 08/2002
4
Pharmaceutical Preparations
IBA
11/2021 - 03/2012
4
Decitabine
FDA Link
01/2021 - 03/2012
4
Enzymes
IBA
01/2021 - 08/2005
4
Bendamustine Hydrochloride
FDA Link
02/2020 - 09/2011
4
Arsenic Trioxide (Trisenox)
FDA Link
11/2019 - 02/2009
4
Peptides (Polypeptides)
IBA
01/2014 - 08/2005
4
Alemtuzumab (Campath)
FDA Link
08/2013 - 09/2006
4
CCAAT-Enhancer-Binding Protein-alpha
IBA
02/2011 - 02/2004
4
Imatinib Mesylate (Gleevec)
FDA Link
11/2007 - 12/2006
4
Hyaluronic Acid (Hyaluronan)
IBA
06/2007 - 09/2002
3
enasidenib
IBA
06/2022 - 01/2021
3
obinutuzumab
IBA
01/2022 - 03/2014
3
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
01/2022 - 08/2010
3
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
01/2022 - 02/2006
3
Phosphotransferases (Kinase)
IBA
01/2022 - 03/2013
3
ivosidenib
IBA
01/2022 - 01/2021
3
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2022 - 05/2008
3
Gemtuzumab (Mylotarg)
FDA Link
11/2021 - 01/2016
3
Valproic Acid (Depakote)
FDA Link
Generic
01/2020 - 06/2014
3
Protein Isoforms (Isoforms)
IBA
01/2020 - 03/2013
3
Dasatinib (BMS 354825)
FDA Link
01/2018 - 10/2008
3
Chlorambucil (Leukeran)
FDA Link
06/2014 - 10/2009
3
NF-kappa B (NF-kB)
IBA
04/2013 - 11/2002
2
Immunomodulating Agents
IBA
01/2022 - 01/2017
2
RNA (Ribonucleic Acid)
IBA
01/2022 - 01/2021
2
ibrutinib
IBA
01/2022 - 01/2018
2
Hydroxyurea (Hydrea)
FDA Link
Generic
12/2021 - 01/2021
2
BI 6727
IBA
08/2021 - 08/2014
2
Circular RNA
IBA
01/2021 - 12/2017
2
Monoclonal Antibodies
IBA
01/2021 - 02/2006
2
fms-Like Tyrosine Kinase 3
IBA
10/2020 - 01/2020
2
Thymidine Kinase
IBA
01/2020 - 01/2018
2
Histone Deacetylase Inhibitors
IBA
01/2020 - 07/2016
2
Cytokines
IBA
01/2019 - 07/2004
2
Insulin-Like Peptides
IBA
01/2019 - 09/2011
2
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2019 - 01/2014
2
Mitoxantrone (Novantrone)
FDA Link
Generic
01/2016 - 06/2013
2
Sunitinib (Sutent)
FDA Link
06/2015 - 02/2005
2
Granzymes (Granzyme)
IBA
01/2014 - 06/2007
Therapy/Procedure
52
Therapeutics
10/2022 - 09/2002
36
Drug Therapy (Chemotherapy)
01/2022 - 08/2002
27
Stem Cell Transplantation
01/2019 - 04/2002
11
Immunotherapy
04/2020 - 09/2002
9
Hematopoietic Stem Cell Transplantation
01/2022 - 12/2006
5
Induction Chemotherapy
01/2022 - 11/2005
4
Cell Transplantation
01/2022 - 02/2008
4
Transplantation
01/2020 - 01/2016
4
Salvage Therapy
11/2019 - 02/2009
2
Aftercare (After-Treatment)
01/2020 - 01/2016